Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Factors Moving Markets - New Research on Franklin Covey, SeaChange International, KemPharm and Bravo Brio Restaurant

FC, SEAC, ZVRA

NEW YORK, NY / ACCESSWIRE / December 17, 2015 / Moments ago, Trader's Choice released new research updates concerning several important developing situations including the following equities: Franklin Covey Co. (NYSE: FC), SeaChange International Inc. (NASDAQ: SEAC), KemPharm Inc. (NASDAQ: KMPH) and Bravo Brio Restaurant Group Inc. (NASDAQ: BBRG). Trader's Choice has perfected the profitable art of picking stocks, cutting through the noise to deliver the top trade, every year. The full Research Packages are being made available to the public on a complimentary basis.

To access our full PDF Research Packages for free, please visit the links below.

============

Full PDF DOWNLOAD Links

(You may have to copy and paste the links into your browser)

FC Research Package: http://www.traders-choice.com/pdf?s=FC

SEAC Research Package: http://www.traders-choice.com/pdf?s=SEAC

KMPH Research Package: http://www.traders-choice.com/pdf?s=KMPH

BBRG Research Package: http://www.traders-choice.com/pdf?s=BBRG

============

Highlights from today's reports include:

On Wednesday, December 16, 2015, the NASDAQ Composite ended at 5,071.13, up 1.52%, the Dow Jones Industrial Average advanced 1.28%, to finish the day at 17,749.09, and the S&P 500 closed at 2,073.07, up 1.45%.

- Franklin Covey Co.'s stock edged lower by 0.49% to close Wednesday's session at USD 16.26. The company's shares oscillated between USD 16.24 and USD 16.49 in trade during the day. The stock recorded a trading volume of 0.084 million shares, which was above its 50-day daily average volume of 0.041 million shares and above its 52-week average volume of 0.044 million shares. Over the last three days, Franklin Covey Co.'s shares have advanced 0.49% and in the past one week the shares have moved up 0.25%. However, over the last three months, the stock has lost 5.68% and in the past six months, the shares have shed 20.80%. Further, the company is trading at a price to earnings ratio of 24.64 and the stock is at a price to book ratio of 2.10. This compares to a historical PE ratio of 25.47 and a historical PB ratio close to 2.15. Additionally, the stock is trading at a price to cash flow ratio of 8.69 and price to sales ratio of 1.26.

- The stock of SeaChange International Inc. gained 1.02% to close Wednesday's session at USD 6.93. The shares of the company moved in the range of USD 6.83 and USD 7.05 during the day. A trading volume of 0.20 million shares was recorded, which was greater than its 150-day daily average volume of 0.14 million shares and above its 52-week average volume of 0.17 million shares. Over the last five days, SeaChange International Inc.'s shares have advanced 2.67% and in the past one month, the shares have gained a momentum of 13.24%. Additionally, over the last three months, the stock has advanced 12.32% while in the past six months; the shares have registered a loss of 10.58%. The stock is trading at a price to book ratio of 1.53 which compares to a historical PB ratio close to 1.35. Further, the stock is trading at a price to sales ratio of 2.10.

- The stock of KemPharm Inc. gained 7.50% to close Wednesday's session at USD 19.50. The shares of the company moved in the range of USD 18.41 and USD 19.50 during the day. A trading volume of 0.05 million shares was recorded, which was lower than its 150-day daily average volume of 0.07 million shares and below its 52-week average volume of 0.09 million shares. Over the last five days, KemPharm Inc.'s shares have advanced 15.80% and in the past one month, the shares have gained a momentum of 36.55%. However, over the last three months, the stock has declined 12.60% while in the past six months; the shares have registered a gain of 6.09%. The shares of the company have been exhibiting some positive momentum and are trading above their 50-day and 200-day simple moving averages by 19.12% and 17.42%, respectively.

- Bravo Brio Restaurant Group Inc.'s stock added 0.11% to close Wednesday's session at USD 9.02. The company's shares oscillated between USD 8.93 and USD 9.31, marking a new 52-week low during the session. The stock recorded a trading volume of 0.15 million shares, which was above its 50-day daily average volume of 0.10 million shares and above its 52-week average volume of 0.11 million shares. Over the last five days, Bravo Brio Restaurant Group Inc.'s shares have declined by 7.87% and in the past one month, the shares have lost 6.14%. Further, the company is trading at a price to earnings ratio of 13.67 and the stock is at a price to book ratio of 2.22. This compares to a historical PE ratio of 21.70 and a historical PB ratio close to 3.65. Additionally, the stock is trading at a price to cash flow ratio of 4.64 and price to sales ratio of 0.32.

About Trader's Choice:

Trader's Choice ("TC") produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and micro-cap stocks. TC has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below.

TC has not been compensated; directly or indirectly; for producing or publishing this document.

PRESS RELEASE PROCEDURES:

The non-sponsored content contained herein has been prepared by a writer (the "Author") and is fact checked and reviewed by a third party research service company (the "Reviewer"). The Reviewer has reviewed and revised the content, as necessary, based on sound investment judgment and publicly available information which is believed to be reliable. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer (collectively referred to as the "Production Team") in any way. The Production Team is compensated on a fixed monthly basis and do not hold any positions of interest in any of the securities mentioned herein. The information in this release has been sourced from a third party data base.

NO WARRANTY

TC, the Author and the Reviewer (collectively referred to as the "Publishers") are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted by the Publishers whatsoever for any direct, indirect or consequential loss arising from the use of this document. The Publishers expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, the Publishers do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

NOT AN OFFERING

This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither TC nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit http://www.traders-choice.com/.

RESTRICTIONS

TC is not available to residents of Belarus, Cuba, Canada, Iran, North Korea, Sudan, Syria or Somalia.

CONTACT

For any questions, inquiries, or comments reach out to us directly at:
E-mail: press (at) traders-choice.com

SOURCE: Trader's Choice



Get the latest news and updates from Stockhouse on social media

Follow STOCKHOUSE Today